Nkarta (NKTX) Metrics: History & Chart

Nkarta, Inc.(NKTX)

Biotechnology · South San Francisco, CA

$2.36-0.17 (-6.53%)

Delayed quote: Oct 6, 2026, 12:50 PM EDT

About Nkarta, Inc.

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

South San Francisco, CA

106 employees

www.nkartatx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Paul J. Hastings

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-5.24%
30D Total Return	-13.36%
YTD Total Return	+36.76%
1Y Total Return	+18.78%
3Y Total Return	+86.02%
5Y Total Return	-90.29%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+36.76%
2025	-25.70%
2024	-62.27%
2023	+10.18%
2022	-60.98%
2021	-75.03%
2020

CAGR TTM	+18.68%
CAGR 3Y	+22.98%
CAGR 5Y	-37.28%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

NKTX Valuation Metrics

NKTX Stock Price Metrics

NKTX Dividend Metrics

NKTX Growth Rate Metrics

NKTX Discounted Cash Flow Metrics

NKTX Returns By Period

NKTX Yearly Returns

NKTX Average Annual Returns By Period (CAGR)

NKTX Revenue Metrics

NKTX PE Ratio Metrics

NKTX PS Ratio Metrics

NKTX PB Ratio Metrics

NKTX Price to Free Cash Flow Ratio Metrics

NKTX Debt to Equity Ratio Metrics

NKTX PEG Ratio Metrics

NKTX FCF Yield

NKTX Earnings Yield

NKTX EBITDA Yield

NKTX OCF Yield

NKTX EV/EBIT Ratio Metrics

NKTX EV/EBITDA Ratio Metrics

NKTX EV/Assets Ratio Metrics

NKTX EV/Sales Ratio Metrics

NKTX Current Ratio Metrics

NKTX Quick Ratio Metrics

NKTX ROIC Metrics

NKTX Return on Assets Metrics

NKTX Return on Equity Metrics

NKTX Net Profit Margin Metrics

NKTX Gross Profit Margin Metrics

NKTX Tax Rate Metrics

PS Ratio	2880871.66
PS Ratio Avg TTM	3112093.93
PS Ratio Avg 3Y	3112093.93
Current VS TTM Avg	-7.43%
Current VS 3Y Avg	-7.43%
Current VS 5Y Avg	-7.43%

PB Ratio	0.76
PB Ratio Avg TTM	0.60
PB Ratio Avg 3Y	0.54
Current VS TTM Avg	+27.14%
Current VS 3Y Avg	+40.70%
Current VS 5Y Avg	-11.70%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.30
Debt/Equity Ratio Avg TTM	0.25
Debt/Equity Ratio Avg 3Y	0.24
Current VS TTM Avg	+18.71%
Current VS 3Y Avg	+23.06%
Current VS 5Y Avg	+24.09%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.70
Ev/Assets Ratio Avg TTM	0.55
Ev/Assets Ratio Avg 3Y	0.46
Current VS TTM Avg	+28.29%
Current VS 3Y Avg	+51.32%
Current VS 5Y Avg	+0.74%

Ev/Sales Ratio	2414811.92
Ev/Sales Ratio Avg TTM	2761537.75
Ev/Sales Ratio Avg 3Y	2761537.75
Current VS TTM Avg	-12.56%
Current VS 3Y Avg	-12.56%
Current VS 5Y Avg	-12.56%

Current Ratio	7.98
Current Ratio Avg TTM	12.91
Current Ratio Avg 3Y	13.45
Current VS TTM Avg	-38.16%
Current VS 3Y Avg	-40.65%
Current VS 5Y Avg	-48.23%

Quick Ratio	7.98
Quick Ratio Avg TTM	12.91
Quick Ratio Avg 3Y	13.45
Current VS TTM Avg	-38.16%
Current VS 3Y Avg	-40.65%
Current VS 5Y Avg	-48.23%

ROIC	(42.11%)
ROIC Avg 3Y	(30.82%)
ROIC Avg 5Y	(29.38%)
Current VS 3Y Avg	-36.61%
Current VS 5Y Avg	-43.33%
Current VS 10Y Avg	-52.12%

ROA	(34.75%)
ROA Avg TTM	(7.28%)
ROA Avg 3Y	(6.07%)
Current VS TTM Avg	-377.01%
Current VS 3Y Avg	-472.83%
Current VS 5Y Avg	-439.57%

ROE	(47.36%)
ROE Avg TTM	(35.31%)
ROE Avg 3Y	(33.09%)
Current VS TTM Avg	-34.13%
Current VS 3Y Avg	-43.14%
Current VS 5Y Avg	-47.49%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%